DURSUN, N. Et Al. 2018. Switching from onabotulinumtoxinA to abobotulinumtoxinA in children with cerebral palsy treated for spasticity: A retrospective safety evaluation. 72nd AACPDM Annual Meeting , (United States Of America).

DURSUN, N., AKARSU, M., Akyuz, M., GÖKBEL, T., KARACAN, Ç., & DURSUN, E., (2018). Switching from onabotulinumtoxinA to abobotulinumtoxinA in children with cerebral palsy treated for spasticity: A retrospective safety evaluation . 72nd AACPDM Annual Meeting, United States Of America

DURSUN, NİGAR Et Al. "Switching from onabotulinumtoxinA to abobotulinumtoxinA in children with cerebral palsy treated for spasticity: A retrospective safety evaluation," 72nd AACPDM Annual Meeting, United States Of America, 2018

DURSUN, NİGAR Et Al. "Switching from onabotulinumtoxinA to abobotulinumtoxinA in children with cerebral palsy treated for spasticity: A retrospective safety evaluation." 72nd AACPDM Annual Meeting , United States Of America, 2018

DURSUN, N. Et Al. (2018) . "Switching from onabotulinumtoxinA to abobotulinumtoxinA in children with cerebral palsy treated for spasticity: A retrospective safety evaluation." 72nd AACPDM Annual Meeting , United States Of America.

@conferencepaper{conferencepaper, author={NİGAR DURSUN Et Al. }, title={Switching from onabotulinumtoxinA to abobotulinumtoxinA in children with cerebral palsy treated for spasticity: A retrospective safety evaluation}, congress name={72nd AACPDM Annual Meeting}, city={}, country={United States Of America}, year={2018}}